Answers are grounded in this paper and cite their sources.
These recommendations refer to the current management in pancreatic ductal adenocarcinoma (PDAC), a neoplasia characterised by an aggressive course and extremely poor prognosis. The recommendations regard diagnosis, surgical, adjuvant and palliative treatment, with consideration given to endoscopic and surgical methods. A vast majority of the statements are based on data obtained in clinical studies and experts' recommendations on PDAC management, including the following guidelines: International Association of Pancreatology/
No takes yet. Share an insight, caveat, or question.
Winter et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: